logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Metastatic HR+ breast cancer: pembrolizumab+chemo does not best chemo for PFS

Phase 2 trial of eribulin chemotherapy with and without immune checkpoint inhibitor.